Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > Price action

<< Previous

Bullboard Posts

Next >>

Comment by TeddyTenBagson Mar 17, 2021 9:29pm

249 Views

Post# 32823125

RE:RE:RE:RE:RE:RE:Price action

Riveting stuff man. Thanks again for the detailed and in depth analysis. Going to sell all of my shares now and re-buy them at $2! Can't wait!

Gilly123 wrote: It was a simple analysis. Mmed went from $2-$4 and found support around $3.75. We are trading under that now and making a little more support but still in a short term bear trend. There is just no set level of support from here to $2 so if sentiment changes slightly it would be relatively easy to crash the price. Saying that, $2 would likely be bought up fast. I want some MMED shares at a deal!

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)